67206-07-9 Usage
Description
D,L-N-acetyl-β-2-thienylalanine is a chemical compound derived from the amino acid phenylalanine, featuring an additional acetyl group and a thienyl group. It is widely utilized in pharmaceutical and medical research for its potential therapeutic effects and as a building block in the synthesis of peptides and small molecules for drug development.
Uses
Used in Pharmaceutical and Medical Research:
D,L-N-acetyl-β-2-thienylalanine is used as a research compound for its potential therapeutic effects in treating various conditions, such as cancer and neurological disorders. Its unique chemical structure allows for a deeper understanding of biological processes and interactions within cells and tissues, making it a valuable tool in pharmacology and medical research.
Used in Drug Development:
As a building block in the synthesis of peptides and small molecules, D,L-N-acetyl-β-2-thienylalanine plays a crucial role in drug development. Its incorporation into these molecules can lead to the creation of novel therapeutic agents with improved efficacy and selectivity for various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 67206-07-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,7,2,0 and 6 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 67206-07:
(7*6)+(6*7)+(5*2)+(4*0)+(3*6)+(2*0)+(1*7)=119
119 % 10 = 9
So 67206-07-9 is a valid CAS Registry Number.
67206-07-9Relevant articles and documents
-
Albertson
, p. 1396 (1950)
-
Synthesis of Heteroaromatic Thyrotropin-releasing Hormone Analogues
Bladon, Christine M.
, p. 1151 - 1158 (2007/10/02)
Novel thyrotropin-releasing hormone (TRH) analogues containing the unnatural and heteroaromatic L-pyrrolylalanine, D-pyrrolylalanine, and L-furylalanine amino acids in position 2 have been synthesised.L-Furylalanine was obtained by the stereospecific hydrolysis of the N-acetyl-D,L-amino acid with acylase I.A protected derivative of D,L-pyrrolylalanine was prepared, the racemate was incorporated into the tripeptide and the LLL and LDL diastereoisomers were separated at the end of the synthesis.
